Pharmacokinetics of levetiracetam in neonates with seizures

Journal of Pediatrics

Volumn 159, Issue 1, 2011, Pages

  Merhar, Stephanie L ^a   Schibler, Kurt R ^a,b   Sherwin, Catherine M ^a   Meinzen Derr, Jareen ^a,b   Shi, Jing ^c   Balmakund, Tonya ^d   Vinks, Alexander A ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c SICHUAN UNIVERSITY   (China)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETIRACETAM; PHENOBARBITAL;

ARTICLE; CLINICAL ARTICLE; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HERPES SIMPLEX; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INFANT; LABORATORY TEST; MALE; NEWBORN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEIZURE; SIDE EFFECT; SOMNOLENCE; VITAL SIGN;

EID: 79958740704     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2011.03.057     Document Type: Article

References (4)

1. Karlsson MO, Sheiner LB. The importance of modeling interoccasion variability in population pharmacokinetic analyses. J Pharmacokinet Biopharm 1993;21:735-50.
2. Anderson BJ, Allegaert K, Holford NH. Population clinical pharmacology of children: modelling covariate effects. Eur J Pediatr 2006;165:819-29.
3. Anderson BJ, Holford NH. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol 2008;48:303-32.
4. Ette EI. Stability and performance of a population pharmacokinetic model. J Clin Pharmacol 1997;37:486-95.